Bart syndrome
Overview
Bart syndrome is a rare genetic disorder (a form of aplasia cutis congenita type VI) present at birth, characterized by the triad of localized absence of skin (often on lower extremities), skin blistering (epidermolysis bullosa), and nail dystrophy. It is typically managed conservatively with wound care to prevent infection, often showing good prognosis.
Symptoms
Cardiomyopathy: Often presents as enlarged/weakened heart muscle (dilated) or left ventricular noncompaction, usually appearing before age 5 and leading to significant heart failure risks.
Neutropenia: Chronic or cyclical low levels of neutrophils (a type of white blood cell), leading to frequent infections, mouth ulcers, and sepsis.
Skeletal Myopathy: Significant muscle weakness, particularly in the proximal muscles, resulting in reduced muscle tone (hypotonia) and fatigue.
Growth Delay: Prepubertal growth retardation and a distinct, thinner physical build.
Metabolic Abnormalities: Increased urinary levels of 3-methylglutaconic acid (\(3\text{-MGCA}\)).
Causes
Gene Mutation: Mutations in the TAFAZZIN (\(TAZ\)) gene, located on the X chromosome, cause the syndrome.
Protein Dysfunction: The \(TAZ\) gene provides instructions to make the protein tafazzin, which is vital for building cardiolipin, a lipid in mitochondrial membranes'.
Mitochondrial Impairment: Defective tafazzin results in low levels of functional cardiolipin and higher levels of immature cardiolipin (monolysocardiolipin).
Energy Deficit: This, in turn, impairs the mitochondria’s ability to produce energy, causing cell death in high-energy tissues like the heart and skeletal muscles.
Risk Factors
Genetic Inheritance: Autosomal dominant, meaning an affected parent has a 50% chance of passing the COL7A1 gene mutation on to their child.
Prenatal/Teratogenic Factors: While largely genetic, potential contributing factors to aplasia cutis congenita (the skin defect) include exposure to certain drugs during pregnancy, such as methimazole, benzodiazepines, cocaine, or valproic acid.
Intrauterine Factors: Potential risks include vascular issues, infections like herpes simplex or varicella-zoster virus, or amniotic band syndrome.
Consanguinity: Some cases are associated with parental consanguinity (closely related parents), suggesting a possible autosomal recessive form in rare instances.
Complications
Infection & Sepsis: The most dangerous complication, resulting from the loss of skin barrier.
Fluid & Electrolyte Loss: Large skin defects can cause rapid dehydration, hypoproteinemia, and hypoglycemia.
Hemorrhage: Bleeding from affected skin areas.
Hypothermia: Inability to regulate temperature due to open wounds.
Skin & Musculoskeletal Issues: Scarring can lead to contractures, resulting in permanent musculoskeletal deformities.
Severe Comorbidities: Severe cases, particularly those linked with junctional epidermolysis bullosa, can include:
Pyloric atresia: Obstruction of the lower stomach, requiring surgical intervention.
Renal/Ureteral Abnormalities: Such as stenosis.
Mucosal Involvement: Ingestion or eye involvement.
Facial Dysmorphism: Including underdeveloped ears, flattened nose, and wide-set eyes.
Diagnosis
Aplasia Cutis Congenita (ACC): Well-defined, ulcerated skin lesions often on the lower extremities.
Epidermolysis Bullosa (EB): Skin fragility leading to blistering.
Nail Dystrophy: Abnormalities of the nails.
Positive Nikolsky sign: Skin detachment upon gentle pressure
Skin Biopsy: Histopathological examination of lesions often reveals sub-epidermal cleavage.
Immunofluorescence Mapping: Used to delineate the specific type of epidermolysis bullosa.
Genetic Testing: Molecular analysis can detect mutations in the COL7A1 gene associated with dystrophic epidermolysis bullosa.
Treatment
Wound Care: Daily gentle cleaning (often with diluted antiseptic baths like chlorhexidine) and application of non-adhesive dressings (such as Vaseline-impregnated gauze) to keep wounds moist and protected.
Infection Control: Topical agents like silver sulfadiazine cream or mupirocin ointment are used to prevent infection in open skin areas.
Blister Management: Sterile needles may be used to drain blisters.
Systemic Care: Prophylactic systemic antibiotics are generally not recommended, but are used if infection occurs.
Surgical Intervention: While rare, large or deep wounds may require skin grafting or local flaps.
Supportive Measures: Minimizing trauma to the skin and monitoring for complications like anemia or electrolyte imbalances.
Type of Doctor Department : Cardiologist (Pediatric/Adult)
.jpg)
Comments
Post a Comment